Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Metabolic Syndrome on Flu Vaccine Efficacy

NCT02653495 is registered in ClinicalTrials.gov with Rockefeller University as lead sponsor.

NCT NCT02653495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02653495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Metabolic Syndrome on Flu Vaccine Efficacy
Lead sponsor
Rockefeller University
Phase
Not applicable
Overall status
Terminated
Start date
January 31, 2016
Completion date
March 31, 2017
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune deficiency, metabolic syndrome